Call 866-997-4948 (Us-Canada Toll Free) Tel: +1-518-618-1030 with your industry research requirements or email the details on sales@researchmoz.us
EpiCast Report Rheumatoid Arthritis Epidemiology Forecast to 2023
Summary
Rheumatoid arthritis (RA) is an autoimmune disease that causes inflammation of the joints. In RA, the bodys immune system attacks the lining of the joints causing an inflammatory response. RA is characterized by joint swelling, pain, and redness, which can cause bone and cartilage erosion, and joint deformity. The disease can lead to premature mortality, disability, and decreased quality of life.
To Browse a Full Report with Toc: http://www.researchmoz.us/epicast-report-rheumatoid-arthritis-epidemiology-forecast-to-2023-report.html
GlobalData epidemiologists forecast an increase in the total prevalent cases of RA in the 8MM, from 12,901,398 total prevalent cases in 2013 to 14,896,291 total prevalent cases in 2023, at an Annual Growth Rate (AGR) of 1.55% over the forecast period. GlobalData epidemiologists also forecast an increase in the diagnosed prevalent cases of RA in the 10MM, from 7,328,399 diagnosed prevalent cases in 2013 to 8,518,398 diagnosed prevalent cases in 2023, at an AGR of 1.62% over the forecast period.
Scope
- The Rheumatoid arthritis (RA) EpiCast Report provides an overview of the risk factors, comorbidities, and the global and historical epidemiological trends for RA in the 10 major markets (10MM) (US, France, Germany, Italy, Spain, UK, Japan, Australia, China, and India). It also includes a 10-year epidemiological forecast for the total prevalent cases of RA, segmented by age (18 to =85 years) and sex in the eight major markets (8MM) (France, Germany, Italy, Spain, UK, Japan, China, and India). Additionally, this report includes a 10-year epidemiological forecast for the diagnosed prevalent cases of RA in the 10MM.
- The RA epidemiology report is written and developed by Masters- and PhD-level...